Hong Kong vs Lower-middle income (World Bank): HIV-positive TB patients on ART (antiretroviral therapy)
Hong Kong
100.0%
in 2024
Lower-middle income (World Bank)
95.0%
in 2024
Hong Kong rank
1st
Lower-middle income (World Bank) rank
3rd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Hong Kong
- Lower-middle income (World Bank)
How they compare
Hong Kong currently reports 100.0% against 95.0% in Lower-middle income (World Bank), a difference of 5.0%.
That makes Hong Kong's figure about 1.1 times Lower-middle income (World Bank)'s.
The two have swapped places 2 times across 18 shared years of data; in 2003 it was Hong Kong ahead.
Hong Kong ranks 1st and Lower-middle income (World Bank) ranks 3rd of 144 countries.
Across the 3 decades both report, Hong Kong averaged higher in 1 and Lower-middle income (World Bank) in 2.
Head to head by decade
| Decade | Hong Kong | Lower-middle income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.4% | 43.0% | 10.4% | Hong Kong |
| 2010s | 31.1% | 80.5% | 49.4% | Lower-middle income (World Bank) |
| 2020s | 92.2% | 94.0% | 1.8% | Lower-middle income (World Bank) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Hong Kong or Lower-middle income (World Bank)?
- Hong Kong, at 100.0% against 95.0% in Lower-middle income (World Bank) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Hong Kong and Lower-middle income (World Bank)?
- 5.0%, with Hong Kong ahead.
- How many years of comparable data are there for Hong Kong and Lower-middle income (World Bank)?
- 18 years are reported by both, from 2003 to 2024.
- How do Hong Kong and Lower-middle income (World Bank) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Hong Kong ranks 1st and Lower-middle income (World Bank) ranks 3rd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.